Scientia Vascular Receives Clearance for the Zoom Wire: Commences Immediate Launch

Scientia Vascular, a leading innovator in the field of neurovascular treatment technology, recently received FDA clearance for its Zoom WireTM 14 guidewire line of interventional guidewires, which are used to gain access during ischemic and hemorrhagic stroke and other challenging neurovascular and peripheral vascular procedures.

Zoom Wire incorporates Scientia Vascular’s proprietary microfabrication design, enabling a new level of performance for the support and delivery of devices within the brain and other parts of the body.

Scientia Vascular Founder and CEO John Lippert stated, “We are pleased to offer the Zoom Wire line of guidewire products at a time when clinicians are in need of more supportive guidewires to deliver therapeutic devices quickly in time-critical interventions. Scientia is launching the Zoom Wire products immediately to key customers who have been requesting this follow-on product to the Aristotle 14, 18, and 24 guidewire families.” Mr. Lippert added: “The Zoom Wire 14 is the first product in a complete Zoom access family of devices, including new guidewires and innovative aspiration and microcatheters, which the company plans for release in 2021.”

Microfabricated guidewire products comprise over 60% of the current US interventional guidewire market, as these are the preferred type of guidewires for procedures ranging from routine to the most complex faced by interventional physicians. Scientia Vascular’s micro-fabrication platform represents the next generation in terms of innovation and performance, and with its recent launch of the Aristotle 18 and Aristotle 24 guidewires, it has quickly become the platform of choice for ischemic stroke procedures.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy